Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$465,863
-$34,987 QoQ
Shares Held
2,142
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Measured Wealth Private Client Group, LLC holds $3,974,731 across 13 Drug Manufacturers - General names. ABBV ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
25,075 | $1,520,798 | |
| 2 | JNJ |
Johnson & Johnson
|
3,336 | $815,451 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,142 | $465,863 | |
| 4 | AMGN |
Amgen Inc
|
905 | $318,424 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,518 | $302,890 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,072 | $288,774 | |
| 7 | LLY |
ELI LILLY & Co
|
114 | $104,853 | |
| 8 | PFE |
Pfizer Inc
|
2,283 | $64,106 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $465,863 | 2,142 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $500,850 | 2,192 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $542,498 | 2,343 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $476,486 | 2,567 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $540,980 | 2,582 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $546,782 | 3,077 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $641,612 | 3,249 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $756,403 | 4,410 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $827,280 | 4,543 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $703,563 | 4,540 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $676,136 | 4,536 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $706,119 | 5,241 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,040,686 | 6,530 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,040,283 | 6,437 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $874,109 | 6,513 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,544,618 | 10,085 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,298,501 | 8,010 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,282,373 | 9,471 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,152,590 | 10,685 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $539,996 | 4,794 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $416,755 | 3,851 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $256,409 | 2,393 | Shares | Sole | 2021-01-20 | |
| 2020-06-30 | $216,290 | 2,203 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||